The Registry of Oncology Outcomes Associated With Testing and Treatment
Public ClinicalTrials.gov record NCT04028479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
Study identification
- NCT ID
- NCT04028479
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Taproot Health
- Industry
- Enrollment
- 167 participants
Conditions and interventions
Conditions
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Adenocarcinoma
- Adenocystic Carcinoma
- Adrenal Cancer
- Anal Cancer
- Appendix Cancer
- Astrocytoma
- Bile Duct Cancer
- Bladder Cancer
- Bone Cancer
- Brain Stem Neoplasms
- Brain Tumor
- Breast Cancer
- CNS Cancer
- Cancer of Colon
- Cancer of Pancreas
- Cancer, Advanced
- Carcinoid Tumor
- Cervical Cancer
- Cholangiocarcinoma
- Chondrosarcoma
- Chronic Myeloid Leukemia
- Colon Cancer
- Colorectal Cancer
- Esophageal Cancer
- Esophagus Cancer
- Fallopian Tube Cancer
- Gestational Trophoblastic Tumor
- Glioblastoma
- Head and Neck Neoplasms
- Hepatic Cancer
- Kidney Cancer
- Larynx Cancer
- Liposarcoma
- Liver Cancer
- Lung Cancer
- Melanoma
- Mesothelioma
- Multiple Endocrine Neoplasia
- Multiple Myeloma
- Nasopharyngeal Carcinoma
- Neuroendocrine Tumors
- Non Hodgkin Lymphoma
- Osteosarcoma
- Ovarian Cancer
- Pancreatic Cancer
- Parathyroid Neoplasms
- Parotid Tumor
- Penile Cancer
- Pharynx Cancer
- Pheochromocytoma
- Prostate Cancer
- Pulmonary Carcinoma
- Rectal Cancer
- Renal Cell Carcinoma
- Salivary Gland Cancer
- Sarcoma
- Sarcoma, Kaposi
- Sarcoma,Soft Tissue
- Skin Cancer
- Small Bowel Cancer
- Small Cell Carcinoma
- Stomach Cancer
- Synovial Sarcoma
- Testicular Cancer
- Testis Cancer
- Thymus Cancer
- Thyroid Cancer
- Tongue Cancer
- Unknown Primary Tumors
- Ureter Cancer
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
- Waldenstrom Macroglobulinemia
Interventions
- Biomarker Testing (L) Diagnostic Test
- Patient Reported Outcomes (P) Other
- Systemic Treatment (T) Drug
Diagnostic Test · Other · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2021
- Primary completion
- Oct 30, 2024
- Completion
- Oct 30, 2024
- Last update posted
- Dec 17, 2024
2021 – 2024
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teton Cancer Institute | Idaho Falls | Idaho | 83404 | — |
| Oncology and Hematology of South Texas | Laredo | Texas | 78041 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04028479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2024 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04028479 live on ClinicalTrials.gov.